Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2

Status

Recruiting 5Not yet recruiting 5Completed 5Withdrawn 3Active not recruiting 2Terminated 1

Sponsor Class

OTHER 5INDUSTRY 3

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Small Cell Lung Carcinoma 3SCLC, Extensive Stage 1Lung Neoplasms 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 57pembrolizumab 55sintilimab 53Specimen Handling 53Surgical Procedures, Operative 52anlotinib 49Fluorouracil 49Magnetic Resonance Spectroscopy 48Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × PM 01183 × Clear all
NCT07258147 2026-05-05

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Sichuan University

Phase 2 Not yet recruiting
30 enrolled
Thoracic

Lung Neoplasms

NCT07153055 2025-12-18

LOTS

Indiana University

Phase 1/2 Not yet recruiting
16 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT07141771 2025-08-26

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting
100 enrolled
Thoracic

SCLC, Extensive Stage

NCT06501976 2024-07-15

An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
9 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06497530 2024-07-12

Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Guangzhou Institute of Respiratory Disease

Phase 2 Not yet recruiting
30 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡